Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease Activity.

CONCLUSION: Rebound occurred frequently in patients with PsA after TNFi discontinuation. TNFi discontinuation after achieving LDA should be carefully considered. PMID: 28966209 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28966209?dopt=Abstract

Source: J Rheumatol - October 1, 2017 Category: Rheumatology Authors: Harrold LR, Stolshek BS, Rebello S, Collier DH, Mutebi A, Wade SW, Malley W, Greenberg JD, Etzel CJ Tags: J Rheumatol Source Type: research

More News: Arthritis | Psoriatic Arthritis | Rheumatology